VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 76 filers reported holding VERACYTE INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $618 | -0.8% | 27,297 | +12.8% | 0.00% | 0.0% |
| Q2 2023 | $623 | +27.1% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $490 | -14.6% | 24,200 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $574 | -99.9% | 24,200 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $395,000 | -16.5% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $473,000 | -32.0% | 24,200 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $696,000 | -18.5% | 24,200 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $854,000 | -12.1% | 22,000 | +2.8% | 0.00% | -33.3% |
| Q3 2021 | $972,000 | +10.7% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $878,000 | -17.2% | 21,400 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,061,000 | +1.2% | 21,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,048,000 | +114.3% | 21,400 | +41.7% | 0.00% | +100.0% |
| Q3 2020 | $489,000 | -40.8% | 15,100 | -55.7% | 0.00% | -60.0% |
| Q3 2019 | $826,000 | +1047.2% | 34,100 | +162.3% | 0.01% | – |
| Q1 2018 | $72,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |